Treatment of Relapsed/Refractory Myeloma (excluding T-cell redirection therapy)
Carfilzomib Dosing in Multiple Myeloma: An International Survey of Oncologist Practices
Rahul Banerjee, MD
Assistant Professor, Clinical Research Division
Fred Hutchinson Cancer Center
Seattle, Washington, United States